CGTX:NASDAQ, Cognition Therapeutics, Inc.

CGTX stock overview

Cognition Therapeutics, Inc. (CGTX:NASDAQ) closed at $0.582 on November 20, 2026, down 3.06% on the day. The stock trades 67.8% below its 52-week high of $1.81 and 5.9% above its 52-week low of $0.550. Over the past year, it lost 61.9%. Cognition Therapeutics, Inc. is part of the Health Care sector.

Key figures

Price
$0.582
Day change
-3.06%
Volume
665,092
Average volume
459,367
Market cap
55M+
52-week range
$0.550 – $1.81
50-day average
$0.813
200-day average
$1.02

Price action over the past year

In 252 trading sessions since November 20, 2025, CGTX closed higher on 105 days (42%). Its best day was March 31, 2026 (+27.73%) and its worst was June 24, 2026 (-38.18%). The stock moved 10% or more in a single session 17 times. It opened at least 5% above the previous day's high 3 times.

Recent signals

CGTX news

About Cognition Therapeutics, Inc.

Cognition Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the discovery and development of innovative, small molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina.

Similar stocks

Find more stocks like CGTX with the Spikes, Gaps, Breakouts and Performance Tracker scanners.

Based on end-of-day data. For information only, not investment advice.